Pulmonary Hypertension: Difference between revisions
No edit summary |
No edit summary |
||
Line 9: | Line 9: | ||
!Subcategories | !Subcategories | ||
|- | |- | ||
|Pulmonary Arterial Hypertension(PAH) | |||
| | | | ||
*Idiopathic PAH(unknown cause) | *Idiopathic PAH(unknown cause) | ||
Line 16: | Line 16: | ||
*PAH with significant venous and / or capillary involvement | *PAH with significant venous and / or capillary involvement | ||
*Persistent pulmonary hypertension of newborn | *Persistent pulmonary hypertension of newborn | ||
|- | |||
Pulmonary hypertension with left heart disease | |Pulmonary hypertension with left heart disease | ||
| | |||
*In disorders of left atrium and ventricle | *In disorders of left atrium and ventricle | ||
of the heart | of the heart | ||
*With Valvular | *With Valvular | ||
|- | |||
Pulmonary hypertension in pulmonary disease and / or hypoxemia | |Pulmonary hypertension in pulmonary disease and / or hypoxemia | ||
| | |||
*Chronic obstructive pulmonary disease(COPD) | *Chronic obstructive pulmonary disease(COPD) | ||
*Interstitial lung disease | *Interstitial lung disease | ||
Line 32: | Line 31: | ||
*Congenital malformations / developmental | *Congenital malformations / developmental | ||
Pulmonary hypertension due to chronic thrombotic and / or embolic processes | |- | ||
|Pulmonary hypertension due to chronic thrombotic and / or embolic processes | |||
|- | |||
| | |||
*Thromboembolic obstruction of proximal pulmonary arteries | *Thromboembolic obstruction of proximal pulmonary arteries | ||
*Thromboembolic obstruction of distal pulmonary arteries | *Thromboembolic obstruction of distal pulmonary arteries | ||
*embolism of the lung(eg tumor, parasites, foreign body, bone marrow) | *embolism of the lung(eg tumor, parasites, foreign body, bone marrow) | ||
|- | |||
Pulmonary hypertension as a result of other diseases and disorders | |Pulmonary hypertension as a result of other diseases and disorders | ||
| | |||
*Sarcoidosis | *Sarcoidosis | ||
*Histiocytosis X | *Histiocytosis X | ||
Line 49: | Line 50: | ||
|} | |} | ||
Evidence of pulmonary hypertension | ==Evidence of pulmonary hypertension== | ||
SPAP <36 mmHg 36-50 mmHg > 50 mmHg | {| class="wikitable" cellpadding="0" cellspacing="0" border="0" width="800px" | ||
TR Vmax < 2.8 m / s 2.9-3.4 m / s > 3.4 m / s | |- | ||
! | |||
RV MPI(TCO-ET/ET) < 0.36 | !Unlikely | ||
RV MPI(TDI) < 0:50 | !Possible | ||
!Likely | |||
|- | |||
|SPAP | |||
|<36 mmHg | |||
|36-50 mmHg | |||
|>50 mmHg | |||
|- | |||
|TR Vmax | |||
|<2.8 m/s | |||
|2.9-3.4 m/s | |||
|>3.4 m/s | |||
|- | |||
|AccT | |||
|>120 ms | |||
|120-60 ms | |||
|<60 ms | |||
|- | |||
|RV MPI (TCO-ET/ET) | |||
|<0.36 | |||
| | |||
| | |||
|- | |||
|RV MPI (TDI) | |||
|<0:50 | |||
| | |||
| | |||
|} | |||
==Calculations for estimating pressure in the pulmonary artery== | |||
{| class="wikitable" cellpadding="0" cellspacing="0" border="0" width="800px" | |||
|- | |||
Systolic PA pressure 4 x(TR Vmax) ² + estimated RA pressure | ! | ||
!Formula | |||
|- | |||
|Systolic PA pressure 4 x(TR Vmax) ² + estimated RA pressure | |||
Diastolic PA pressure 4 x(PR Ved) ² + estimated RA pressure | Diastolic PA pressure 4 x(PR Ved) ² + estimated RA pressure | ||
Mean PA pressure 0.3 x systolic PA pressure + 0.6 x diastolic PA pressure | Mean PA pressure 0.3 x systolic PA pressure + 0.6 x diastolic PA pressure | ||
Line 65: | Line 98: | ||
4 x(PR Vmax) ² + estimated RA pressure | 4 x(PR Vmax) ² + estimated RA pressure | ||
TR PGmean + estimated RA pressure | TR PGmean + estimated RA pressure | ||
|} | |||
Example severe pulmonary hypertension | Example severe pulmonary hypertension | ||
Revision as of 16:55, 25 January 2014
Pulmonary hypertension is a rare cause of high blood pressure(hypertension) in the pulmonary artery(pulmonary artery). When the blood vessels of the lungs becomes damaged, such as in pulmonary arterial hypertension, the thickening and stiffening of the pulmonary artery walls occur which causes deviations in the vessel wall. The consequence of this is that the pressure in the pulmonary artery rises and also in the RV. PH is a pressure load on the right heart. Click here to see an animation about PH.
WHO classification
Pulmonary hypertension is classified by the World Health Organization (WHO) as the place where the obstruction lies.
Classification | Subcategories |
---|---|
Pulmonary Arterial Hypertension(PAH) |
|
Pulmonary hypertension with left heart disease |
of the heart
|
Pulmonary hypertension in pulmonary disease and / or hypoxemia |
chronic exposure to high altitude
|
Pulmonary hypertension due to chronic thrombotic and / or embolic processes | |
| |
Pulmonary hypertension as a result of other diseases and disorders |
|
Evidence of pulmonary hypertension
Unlikely | Possible | Likely | |
---|---|---|---|
SPAP | <36 mmHg | 36-50 mmHg | >50 mmHg |
TR Vmax | <2.8 m/s | 2.9-3.4 m/s | >3.4 m/s |
AccT | >120 ms | 120-60 ms | <60 ms |
RV MPI (TCO-ET/ET) | <0.36 | ||
RV MPI (TDI) | <0:50 |
Calculations for estimating pressure in the pulmonary artery
Formula | |
---|---|
Systolic PA pressure 4 x(TR Vmax) ² + estimated RA pressure
Diastolic PA pressure 4 x(PR Ved) ² + estimated RA pressure Mean PA pressure 0.3 x systolic PA pressure + 0.6 x diastolic PA pressure 90 - (0.62 x ACCT) if Acct < 120ms 4 x(PR Vmax) ² + estimated RA pressure TR PGmean + estimated RA pressure |
Example severe pulmonary hypertension
Short acct with "systolic notch" Flattened septum
Increased Systolic PA pressure Increased MPI, extension of isovolumetric times. Source : Eur Respir Rev 2012 ; 21: 125, 239-248
References
- Habib G, Badano L, Tribouilloy C, Vilacosta I, Zamorano JL, Galderisi M, Voigt JU, Sicari R, Cosyns B, Fox K, Aakhus S, and European Association of Echocardiography. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010 Mar;11(2):202-19. DOI:10.1093/ejechocard/jeq004 |